Skip to main navigation Skip to search Skip to main content

Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity

  • Yu Xuan Lyu*
  • , Qiang Fu
  • , Dominika Wilczok
  • , Kejun Ying
  • , Aaron King
  • , Adam Antebi
  • , Aleksandar Vojta
  • , Alexandra Stolzing
  • , Alexey Moskalev
  • , Anastasia Georgievskaya
  • , Andrea B. Maier
  • , Andrea Olsen
  • , Anja Groth
  • , Anna Katharina Simon
  • , Anne Brunet
  • , Aisyah Jamil
  • , Anton Kulaga
  • , Asif Bhatti
  • , Benjamin Yaden
  • , Bente Klarlund Pedersen
  • Björn Schumacher, Boris Djordjevic, Brian Kennedy, Chieh Chen, Christine Yuan Huang, Christoph U. Correll, Coleen T. Murphy, Collin Y. Ewald, Danica Chen, Dario Riccardo Valenzano, Dariusz Sołdacki, David Erritzoe, David Meyer, David A. Sinclair, Eduardo Nunes Chini, Emma C. Teeling, Eric Morgen, Eric Verdin, Erik Vernet, Estefano Pinilla, Evandro F. Fang, Evelyne Bischof, Evi M. Mercken, Fabian Finger, Folkert Kuipers, Frank W. Pun, Gabor Gyülveszi, Gabriele Civiletto, Garri Zmudze, Gil Blander, Harold A. Pincus, Joshua McClure, James L. Kirkland, James Peyer, Jamie N. Justice, Jan Vijg, Jennifer R. Gruhn, Jerry McLaughlin, Joan Mannick, João Passos, Joseph A. Baur, Joe Betts-LaCroix, John M. Sedivy, John R. Speakman, Jordan Shlain, Julia von Maltzahn, Katrin I. Andreasson, Kelsey Moody, Konstantinos Palikaras, Kristen Fortney, Laura J. Niedernhofer, Lene Juel Rasmussen, Liesbeth M. Veenhoff, Lisa Melton, Luigi Ferrucci, Marco Quarta, Maria Koval, Maria Marinova, Mark Hamalainen, Maximilian Unfried, Michael S. Ringel, Milos Filipovic, Mourad Topors, Natalia Mitin, Nawal Roy, Nika Pintar, Nir Barzilai, Paolo Binetti, Parminder Singh, Paul Kohlhaas, Paul D. Robbins, Paul Rubin, Peter O. Fedichev, Petrina Kamya, Pura Muñoz-Canoves, Rafael de Cabo, Richard G.A. Faragher, Rob Konrad, Roberto Ripa, Robin Mansukhani, Sabrina Büttner, Sara A. Wickström, Sebastian Brunemeier, Sergey Jakimov, Shan Luo, Sharon Rosenzweig-Lipson, Shih Yin Tsai, Stefanie Dimmeler, Thomas A. Rando, Tim R. Peterson, Tina Woods, Tony Wyss-Coray, Toren Finkel, Tzipora Strauss, Vadim N. Gladyshev, Valter D. Longo, Varun B. Dwaraka, Vera Gorbunova, Victoria A. Acosta-Rodríguez, Vincenzo Sorrentino, Vittorio Sebastiano, Wenbin Li, Yousin Suh, Alex Zhavoronkov*, Morten Scheibye-Knudsen*, Daniela Bakula*
*Corresponding author for this work
  • Southern University of Science and Technology
  • Max Planck Institute for Biology of Ageing
  • Binzhou Medical University
  • Shanghai Jiao Tong University
  • Shandong Cellogene Pharmaceutics Co. Ltd.
  • Duke Kunshan University
  • Duke University
  • Harvard University
  • Foresight Institute
  • University of Cologne
  • University of Zagreb
  • Loughborough University
  • Lobachevsky State University of Nizhni Novgorod
  • HautAI OÜ
  • National University of Singapore
  • California Institute of Technology
  • University of Copenhagen
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association
  • University of Oxford
  • Stanford University
  • Insilico Medicine AI Limited
  • Romanian Academy
  • America’s
  • Indiana University-Purdue University Indianapolis
  • Biotechnologies Ltd.
  • University College London
  • University of California at Los Angeles
  • The University of Hong Kong
  • Hofstra
  • Charité – Universitätsmedizin Berlin
  • Princeton University
  • ETH Zurich - Institute for Particle Physics and Astrophysics (IPA)
  • University of California at Berkeley
  • Friedrich Schiller University Jena
  • Longevity Center Europe
  • Imperial College London
  • Mayo Clinic Rochester, MN
  • University College Dublin
  • BioAge Labs
  • Buck Institute for Age Research
  • Research and Early Development
  • VitaDao
  • University of Oslo
  • University of Groningen
  • Insilico Medicine Hong Kong Ltd.
  • Rejuveron Life Sciences AG
  • DSM-Firmenich AG
  • LongeVC
  • InsideTracker
  • Columbia University
  • Maxwell Biosciences, Inc.
  • Inc.
  • XPRIZE Foundation
  • Albert Einstein College of Medicine
  • Life Biosciences, Inc.
  • Cambrian Bio Inc. PipeCo
  • Mayo Clinic College of Medicine and Science
  • University of Pennsylvania
  • Retro Biosciences
  • Brown University
  • Shenzhen Institute of Advanced Technology
  • Private Medical
  • Brandenburg University of Technology
  • Inc.
  • National and Kapodistrian University of Athens
  • University of Minnesota Twin Cities
  • Springer Nature
  • National Institutes of Health
  • Rubedo Life Sciences
  • Turn Biotechnologies
  • Phaedon Institute
  • University of New South Wales
  • Longevity Acceleration Fund
  • Boston Consulting Group
  • Leibniz-Institut für Analytische Wissenschaften
  • Inc.
  • Sapere Bio
  • Holmusk
  • AniBiome
  • Molecule
  • Gero
  • University of Montreal
  • Altos Labs
  • University of Brighton
  • Biolytica
  • Deciduous Therapeutics
  • Stockholm University
  • Max Planck Institute for Molecular Biomedicine
  • Healthspan Capital
  • Goethe University Frankfurt
  • Inc.
  • National Innovation Centre for Ageing
  • University of Pittsburgh
  • Sheba Medical Center at Tel Hashomer
  • University of Southern California
  • TruDiagnostic, LLC
  • University of Rochester
  • University of Texas Southwestern Medical Center
  • Capital Medical University

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

The recent unprecedented progress in ageing research and drug discovery brings together fundamental research and clinical applications to advance the goal of promoting healthy longevity in the human population. We, from the gathering at the Aging Research and Drug Discovery Meeting in 2023, summarised the latest developments in healthspan biotechnology, with a particular emphasis on artificial intelligence (AI), biomarkers and clocks, geroscience, and clinical trials and interventions for healthy longevity. Moreover, we provide an overview of academic research and the biotech industry focused on targeting ageing as the root of age-related diseases to combat multimorbidity and extend healthspan. We propose that the integration of generative AI, cutting-edge biological technology, and longevity medicine is essential for extending the productive and healthy human lifespan.

Original languageEnglish
Pages (from-to)12955-12976
Number of pages22
JournalAging
Volume16
Issue number20
DOIs
StatePublished - 2024

Funding

FundersFunder number
Li Ka Shing Faculty of Medicine, University of Hong Kong
Stockholms Universitet
University of Minnesota
Michael Antonov Foundation
Noaber Foundation
Insilico Medicine
Neye Foundation
Connor Fund
National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute
Edythe Broad Center of Regenerative Medicine and Stem Cell Research
Max-Planck-Gesellschaft
Wenner-Gren Institute
Jonsson Cancer Center Foundation
National University Health System
USA 105Department of Molecular Biosciences
European Commission
VitaDao
Oppenheimer Program
University of Pittsburgh
Margaret E. Early Medical Research Trust
California Institute of Regenerative Medicine
Medicine Canada Inc.
Labs Inc.
Goethe-Universität Frankfurt am Main
European Research Council
National Institute on Aging
Centre for Physical Activity Research
Southern University of Science and Technology
National Eye InstituteR01AG063543, 1R43EY034403-01, U54AG076041, U54AG079754, ERC-2016-AdG-741966
TrygFonden20045, 125132, ID 101390
Natural Science Foundation of Shandong Province2021XDHZ082, ZR2023MH262
Irish Research CouncilIRCLA/2017/58
Fondation Santé19656
Lundbeck FoundationR324-2019-1492
Science Foundation Ireland19/FFP/6790
National Academy of MedicineAG82764, AG68667
Max Planck Institute for Molecular Biomedicine, Münster, Germany 107Healthspan CapitalCA 94530
California Institute for Regenerative Medicine-14096, ERC-2016AdG-741966
Tel Aviv UniversityCA 90001
National Institutes of HealthCA 94107, U01ES029519, P01AG017242, R01AG063404, R01AG 063389, R33AG061456, UG3CA268103, P01AG047200, U19AG056278, R01DK 117481, R01AG82708, R37AG013925, U01HL145560, R01AG068048, P01 AG062413, R01AG082105
Uddannelses- og Forskningsministeriet0238-00003B
Wellcome Trust220784/Z/20/Z
National University of SingaporeNUHSRO/2022/047/Startup/11
Indiana Clinical and Translational Sciences InstituteUL1TR000124
Novo Nordisk Foundation Challenge ProgrammeNNF17OC0027812
Nordea-fonden02-2017-1749
University of CaliforniaCA 90095

    Keywords

    • artificial intelligence
    • biotechnology
    • healthy longevity

    Fingerprint

    Dive into the research topics of 'Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity'. Together they form a unique fingerprint.

    Cite this